Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

New Ultrasound Exam Steps for Venous Insufficiency Studies

Clear Image Devices LLC (CiD) announces the release of a new step platform to be used for standing patient ultrasound venous insufficiency studies. (Item #: 24601, Price: $1950).

Thumbnail

Radiology patient portal supports consumer education

Radiology patient portals are a feasible means to automatically structure and combine radiology reports with corresponding imaging studies, consequently giving patients access to high quality information about their disease or condition, according to a study published in the November issue of the Journal of the American Medical Informatics Association.

Thumbnail

Dynamic contrast-enhanced MRI benefits HCC

Dynamic contrast-enhanced MRI (DCE-MRI) is useful in not only quantifying the perfusion metrics of hepatocellular carcinoma (HCC) and liver parenchyma, but also assessing perfusion changes after HCC chemoembolization, according to a study published in the October issue of the American Journal of Roentgenology.

Mixed results from phase III flurpiridaz PET trial

Lantheus Medical Imaging has announced preliminary phase III clinical trial results for F-18 flurpiridaz as a diagnostic PET agent for myocardial perfusion imaging indicating high sensitivity but potentially lagging specificity for the detection of CAD.

Thumbnail

An unforeseen marriage: Diabetes drug and chemoradiation effectively treat NSCLC

Pairing the diabetes drug, metformin, with chemoradiation therapy treatment for aggressive lung cancer may slow tumor growth and recurrence, according to researchers at the Perelman School of Medicine at the University of Pennsylvania.

Regadenoson on FDA watch for adverse effects

The FDA has added regadenoson, an adenosine myocardial perfusion agent used during cardiac stress tests, to its most recent watch list for potentially life-threatening side effects.

Thumbnail

ACR Appropriateness Criteria for palpable breast masses released

The ACR Appropriateness Criteria for palpable breast masses, which provides thorough recommendations for particular imaging methods and patient situations, was published in the October issue of the Journal of the American College of Radiology.

Thumbnail

Unnecessary adnexal lesion follow-ups eliminated

A quality improvement initiative reduced unnecessary imaging referrals for adnexal lesions by a team of researchers at the Virginia Mason Medical Center, according to a study published online Oct. 18 in the Journal of the American College of Radiology.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.